JAFCO Co., Ltd. Introduces "SQA Series" Semen Analysis Device, Capable of Measurement in Approximately 75 Seconds, at the Japanese Urological Association Annual Meeting
JAFCO Co., Ltd. showcased its latest models, "SQA-iO" and the dedicated imaging option "SQA-VU," from the "SQA series" of semen analysis devices at the 113th Annual Meeting of the Japanese Urological Association. This solution addresses challenges in male infertility testing, such as delays in starting examinations and hurdles for medical institutions to adopt, by enabling immediate in-clinic result confirmation.
📋 Article Processing Timeline
- 📰 Published: May 12, 2026 at 23:40
- 🔍 Collected: May 12, 2026 at 15:02
- 🤖 AI Analyzed: May 12, 2026 at 15:44 (41 min after Collected)
JAFCO Co., Ltd. (Representative: Junko Morita) exhibited at the 113th Annual Meeting of the Japanese Urological Association held in 2026, proposing an in-clinic semen testing solution that allows for immediate result confirmation. This addresses issues in the male infertility field, such as delays in initiating examinations and high barriers for medical institutions to adopt new systems.
At this exhibition, the latest model of the semen analysis device "SQA series," "SQA-iO," and its dedicated imaging option "SQA-VU" were introduced, presenting a concrete operational image for establishing a complete in-clinic semen testing system in medical institutions.
■ Current Status Surrounding Male Infertility Testing
While approximately half of infertility causes are attributed to the male side, male-side examinations often take a long time to initiate due to psychological barriers, delays in seeking medical attention, and the perception that such tests should be performed at specialized facilities.
Furthermore, in clinical settings, challenges may arise such as the time required for results to be returned from external testing laboratories, the need for repeat visits, and the fragmentation of opportunities to explain test results.
Against this backdrop, there is a growing demand for making male infertility testing more accessible and for establishing systems that allow for rapid in-clinic confirmation of results within medical institutions.
■ In-Clinic Complete Semen Testing Solution
JAFCO Co., Ltd.'s proposed "SQA series" is a semen analysis device that supports the in-clinic implementation of semen testing.
Key features are as follows:
- Rapid measurement in approximately 75 seconds
- Simple operation without the need for a microscope
- Designed for operation by in-clinic staff
- Automatic analysis of approximately 20 parameters, including sperm concentration, motility, and SMI (Sperm Motility Index)
- Report design that is easy for patients to understand
Latest Series SQA-iO + VU
This makes it easier for medical institutions to conduct "examination," "result presentation," and "doctor's explanation" on the same day, which is expected to improve patient understanding, reduce the burden of repeat visits, and streamline the clinical workflow.
Comparison of outsourced testing and in-clinic complete testing
■ Exhibition Content at the 113th Annual Meeting of the Japanese Urological Association
113th Annual Meeting of the Japanese Urological Association, Event Hall Booth E-19
At this conference, the latest model "SQA-iO" and the SQA-iO dedicated imaging option "SQA-VU" were exhibited.
【Exhibits】
- SQA-iO (Latest model of SQA series)
- SQA-VU (SQA-iO dedicated imaging option)
- "Manga Male Infertility Story"
Through live demonstrations, the entire process from sample measurement to result display and doctor's explanation was showcased, demonstrating the potential for in-clinic complete testing in urology and other medical institutions.
In particular, the ability to confirm test results in a short time and to easily grasp sperm conditions using indicators such as SMI provided attendees with a concrete image of how the system can be utilized.
■ Expansion into Preconception Care
In recent years, interest in "preconception care," which involves checking the health status of both men and women before pregnancy to prepare for future pregnancy and childbirth, has been growing.
Within this context, semen testing is becoming increasingly important not only for infertility treatment but also as a test for couples to understand their own health status and take necessary actions early.
JAFCO Co., Ltd. will promote the widespread adoption of male infertility testing, support the establishment of in-clinic testing systems in medical institutions, and expand into the field of preconception care through the SQA series.
■ Future Outlook
JAFCO Co., Ltd. will continue to lower the barriers to male infertility testing and support the development of testing environments that are easier for more medical institutions to adopt.
Moving forward, we will contribute to realizing high-value clinical experiences for both patients and healthcare providers by offering equipment and services that meet the needs of the medical field.
■ Company Profile
Company Name: JAFCO Co., Ltd.
Location: 2-6-15 Tsurumaki, Setagaya-ku, Tokyo 154-0016
Representative: Junko Morita
Business Activities: Import, sales, and support of medical devices, primarily in the male infertility field
URL: https://www.jaffcoltd.com
Keywords:
At this exhibition, the latest model of the semen analysis device "SQA series," "SQA-iO," and its dedicated imaging option "SQA-VU" were introduced, presenting a concrete operational image for establishing a complete in-clinic semen testing system in medical institutions.
■ Current Status Surrounding Male Infertility Testing
While approximately half of infertility causes are attributed to the male side, male-side examinations often take a long time to initiate due to psychological barriers, delays in seeking medical attention, and the perception that such tests should be performed at specialized facilities.
Furthermore, in clinical settings, challenges may arise such as the time required for results to be returned from external testing laboratories, the need for repeat visits, and the fragmentation of opportunities to explain test results.
Against this backdrop, there is a growing demand for making male infertility testing more accessible and for establishing systems that allow for rapid in-clinic confirmation of results within medical institutions.
■ In-Clinic Complete Semen Testing Solution
JAFCO Co., Ltd.'s proposed "SQA series" is a semen analysis device that supports the in-clinic implementation of semen testing.
Key features are as follows:
- Rapid measurement in approximately 75 seconds
- Simple operation without the need for a microscope
- Designed for operation by in-clinic staff
- Automatic analysis of approximately 20 parameters, including sperm concentration, motility, and SMI (Sperm Motility Index)
- Report design that is easy for patients to understand
Latest Series SQA-iO + VU
This makes it easier for medical institutions to conduct "examination," "result presentation," and "doctor's explanation" on the same day, which is expected to improve patient understanding, reduce the burden of repeat visits, and streamline the clinical workflow.
Comparison of outsourced testing and in-clinic complete testing
■ Exhibition Content at the 113th Annual Meeting of the Japanese Urological Association
113th Annual Meeting of the Japanese Urological Association, Event Hall Booth E-19
At this conference, the latest model "SQA-iO" and the SQA-iO dedicated imaging option "SQA-VU" were exhibited.
【Exhibits】
- SQA-iO (Latest model of SQA series)
- SQA-VU (SQA-iO dedicated imaging option)
- "Manga Male Infertility Story"
Through live demonstrations, the entire process from sample measurement to result display and doctor's explanation was showcased, demonstrating the potential for in-clinic complete testing in urology and other medical institutions.
In particular, the ability to confirm test results in a short time and to easily grasp sperm conditions using indicators such as SMI provided attendees with a concrete image of how the system can be utilized.
■ Expansion into Preconception Care
In recent years, interest in "preconception care," which involves checking the health status of both men and women before pregnancy to prepare for future pregnancy and childbirth, has been growing.
Within this context, semen testing is becoming increasingly important not only for infertility treatment but also as a test for couples to understand their own health status and take necessary actions early.
JAFCO Co., Ltd. will promote the widespread adoption of male infertility testing, support the establishment of in-clinic testing systems in medical institutions, and expand into the field of preconception care through the SQA series.
■ Future Outlook
JAFCO Co., Ltd. will continue to lower the barriers to male infertility testing and support the development of testing environments that are easier for more medical institutions to adopt.
Moving forward, we will contribute to realizing high-value clinical experiences for both patients and healthcare providers by offering equipment and services that meet the needs of the medical field.
■ Company Profile
Company Name: JAFCO Co., Ltd.
Location: 2-6-15 Tsurumaki, Setagaya-ku, Tokyo 154-0016
Representative: Junko Morita
Business Activities: Import, sales, and support of medical devices, primarily in the male infertility field
URL: https://www.jaffcoltd.com
Keywords: